Mandrake Bio raises Rs 16 crore to build AI-powered gene-editing platform for agriculture, medicine
Bengaluru startup Mandrake Bio secured sixteen crore rupees in new funding. This capital will expand their AI and biophysics teams for platform validation. The company uses generative AI to design novel gene-editing enzymes. This technology promises faster development for improved crops and therapies. Mandrake Bio aims to significantly reduce gene-editing development timelines and costs.
Why this byte is shareable
Signal quality
observed
Confidence badge and source context included.
Entity anchor
Business
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
Latency changes affect UX and cost envelopes. Revalidate timeout budgets and route-level fallbacks.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
Mandrake Bio raises Rs 16 crore to build AI-powered gene-editing platform for agriculture, medicine Why it matters: Latency changes affect UX and cost envelopes. Revalidate timeout budgets and route-level fallbacks. Source: The Economic Times https://a2zai.ai/bytes/mandrake-...
Permalink: https://a2zai.ai/bytes/mandrake-bio-raises-rs-16-crore-to-build-ai-powered-gene-editing-platform-for-ag-21412784
Social card: https://a2zai.ai/bytes/mandrake-bio-raises-rs-16-crore-to-build-ai-powered-gene-editing-platform-for-ag-21412784/opengraph-image